CYTK
CYTOKINETICS INC
NASDAQ · Healthcare · Biotechnology · US
$68.78
−1.63%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 38.43x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -55.12x
- Price / sales
- 134.75x
- Price / cash flow
- -17.21x
Enterprise value
- Enterprise value
- $9.7B
- EV / sales
- 136.23x
- EV / EBITDA
- -11.81x
- EV / EBIT
- -13.72x
- Market cap
- $9.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026